Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Drug ointment, 0,2% |
Is a |
False |
Ointment |
Inferred relationship |
Some |
|
Drug ointment, 2,5% |
Is a |
False |
Ointment |
Inferred relationship |
Some |
|
Drug ointment, 0,25% |
Is a |
False |
Ointment |
Inferred relationship |
Some |
|
Drug ointment, 1% |
Is a |
False |
Ointment |
Inferred relationship |
Some |
|
Drug ointment, 0,05% |
Is a |
False |
Ointment |
Inferred relationship |
Some |
|
Drug ointment, 0,1% |
Is a |
False |
Ointment |
Inferred relationship |
Some |
|
Drug ointment, 0,025% |
Is a |
False |
Ointment |
Inferred relationship |
Some |
|
Eye ointment |
Is a |
False |
Ointment |
Inferred relationship |
Some |
|
Ear ointment |
Is a |
False |
Ointment |
Inferred relationship |
Some |
|
Nasal ointment |
Is a |
False |
Ointment |
Inferred relationship |
Some |
|
Conventional release ear or eye or nose ointment (dose form) |
Is a |
False |
Ointment |
Inferred relationship |
Some |
|
Vaginal ointment |
Is a |
False |
Ointment |
Inferred relationship |
Some |
|
Rectal ointment |
Is a |
False |
Ointment |
Inferred relationship |
Some |
|
Conventional release vapor ointment for inhalation (dose form) |
Is a |
False |
Ointment |
Inferred relationship |
Some |
|
Cutaneous ointment |
Is a |
False |
Ointment |
Inferred relationship |
Some |
|
Conventional release ear or eye ointment (dose form) |
Is a |
False |
Ointment |
Inferred relationship |
Some |
|
dexametason 1 mg + neomycinsulfat 3,5 mg, salva |
Has manufactured dose form |
False |
Ointment |
Inferred relationship |
Some |
|
Dithranol 10 mg/g cutaneous ointment |
Has manufactured dose form |
False |
Ointment |
Inferred relationship |
Some |
|
kalcipotriol 50 mikrogram/g + betametason 500 mikrogram/g, salva |
Has manufactured dose form |
False |
Ointment |
Inferred relationship |
Some |
|
Product containing precisely coal tar 10 milligram/1 gram and dithranol 1.1 milligram/1 gram and salicylic acid 16 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
False |
Ointment |
Inferred relationship |
Some |
|
katekin 15 %, salva för lokalt bruk |
Has manufactured dose form |
False |
Ointment |
Inferred relationship |
Some |
|
kamomillextrakt 10,5 %, salva |
Has manufactured dose form |
False |
Ointment |
Inferred relationship |
Some |
|
mikonazol 0,25 % / zinkoxid 15 % / vitt vaselin 81,35 %, salva för lokalt bruk |
Has manufactured dose form |
False |
Ointment |
Inferred relationship |
Some |
|
Cod liver oil 114 mg/g and zinc oxide 380 mg/g cutaneous ointment |
Has manufactured dose form |
False |
Ointment |
Inferred relationship |
Some |
|
bensokain 14 % vikt per vikt + butamben 2 % vikt per vikt + tetrakainhydroklorid 2 % vikt per vikt, salva |
Has manufactured dose form |
False |
Ointment |
Inferred relationship |
Some |
|
hydrokortisonacetat 2,5 % vikt per vikt + pramoxinhydroklorid 1 % vikt per vikt, salva |
Has manufactured dose form |
False |
Ointment |
Inferred relationship |
Some |
|
fluocinolonacetonid 0,025 % + kliokinol 3 %, salva |
Has manufactured dose form |
False |
Ointment |
Inferred relationship |
Some |
|
gentamicinsulfat 0,3 % vikt per vikt + prednisolonacetat 0,6 % vikt per vikt, salva |
Has manufactured dose form |
False |
Ointment |
Inferred relationship |
Some |
|
kollagenas 250 enheter/g, salva |
Has manufactured dose form |
False |
Ointment |
Inferred relationship |
Some |
|
Product containing precisely benzalkonium chloride 1 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
False |
Ointment |
Inferred relationship |
Some |
|
nitrofurazon 0,2 %, salva |
Has manufactured dose form |
False |
Ointment |
Inferred relationship |
Some |
|
Product containing precisely calcipotriol 50 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
False |
Ointment |
Inferred relationship |
Some |
|
Prednicarbate 1 mg/g cutaneous ointment |
Has manufactured dose form |
False |
Ointment |
Inferred relationship |
Some |
|
Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
False |
Ointment |
Inferred relationship |
Some |
|
koltjära 12 % + svalvel 4 % + salicylsyra 2 %, salva |
Has manufactured dose form |
False |
Ointment |
Inferred relationship |
Some |
|
Product containing precisely heparinoid 8 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
False |
Ointment |
Inferred relationship |
Some |
|
dexametason 1 mg + tobramycin 3 mg, salva |
Has manufactured dose form |
False |
Ointment |
Inferred relationship |
Some |
|
Povidone iodine 100 mg/g cutaneous ointment |
Has manufactured dose form |
False |
Ointment |
Inferred relationship |
Some |
|
Clorquinaldol 30 mg/g and hydrocortisone butyrate 1 mg/g cutaneous ointment |
Has manufactured dose form |
False |
Ointment |
Inferred relationship |
Some |
|
halobetasolpropionat 0,05 %, salva |
Has manufactured dose form |
False |
Ointment |
Inferred relationship |
Some |
|
Product containing precisely hydrocortisone acetate 10 milligram/1 gram and sodium fusidate 20 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
False |
Ointment |
Inferred relationship |
Some |
|
Betamethasone (as betamethasone dipropionate) 500 microgram/g and calcipotriol 50 microgram/g cutaneous ointment |
Has manufactured dose form |
False |
Ointment |
Inferred relationship |
Some |
|
Hydrocortisone 10 mg/g and oxytetracycline (as oxytetracycline hydrochloride) 30 mg/g cutaneous ointment |
Has manufactured dose form |
False |
Ointment |
Inferred relationship |
Some |
|
deoxiribonukleas 6 666 enheter + plasmin 10 enheter, salva |
Has manufactured dose form |
False |
Ointment |
Inferred relationship |
Some |
|
Product containing precisely clioquinol 30 milligram/1 gram and hydrocortisone 10 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
False |
Ointment |
Inferred relationship |
Some |
|
triamcinolon 0,1 % + klortetracyklinhydroklorid 3 %, salva |
Has manufactured dose form |
False |
Ointment |
Inferred relationship |
Some |
|
bensoe- och salicylsyrasalva |
Has manufactured dose form |
False |
Ointment |
Inferred relationship |
Some |
|
Product containing precisely Podophyllum resin 200 milligram/1 gram and salicylic acid 250 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
False |
Ointment |
Inferred relationship |
Some |
|
Hydrocortisone 10 mg/g and miconazole nitrate 20 mg/g cutaneous ointment |
Has manufactured dose form |
False |
Ointment |
Inferred relationship |
Some |
|
dexametason 0,1 % vikt per volym + neomycinsulfat 3,5 mg + polymyxin B-sulfat 10 000 enheter, salva |
Has manufactured dose form |
False |
Ointment |
Inferred relationship |
Some |
|
Product containing precisely mineral oil 50 milligram/1 gram and white petrolatum 950 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
False |
Ointment |
Inferred relationship |
Some |
|
heparinoid 50 enheter/gram + hyaluronidas150 enheter/gram, salva |
Has manufactured dose form |
False |
Ointment |
Inferred relationship |
Some |
|
Product containing precisely mineral oil 500 milligram/1 gram and white petrolatum 500 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
False |
Ointment |
Inferred relationship |
Some |
|
Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment |
Has manufactured dose form |
False |
Ointment |
Inferred relationship |
Some |
|
paraffinsalva |
Has manufactured dose form |
False |
Ointment |
Inferred relationship |
Some |
|
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment |
Has manufactured dose form |
False |
Ointment |
Inferred relationship |
Some |
|
nystatin + triamcinolonacetonid 10 000 IE/mg, salva |
Has manufactured dose form |
False |
Ointment |
Inferred relationship |
Some |
|
antralin, salva |
Has manufactured dose form |
False |
Ointment |
Inferred relationship |
Some |
|
nystatin + triamcinolonacetonid 10 000 IE/mg, salva |
Has manufactured dose form |
False |
Ointment |
Inferred relationship |
Some |
|
Nasal ointment |
Has basic dose form (attribute) |
True |
Ointment |
Inferred relationship |
Some |
|
Rectal ointment |
Has basic dose form (attribute) |
True |
Ointment |
Inferred relationship |
Some |
|
Vaginal ointment |
Has basic dose form (attribute) |
True |
Ointment |
Inferred relationship |
Some |
|
Cutaneous ointment |
Has basic dose form (attribute) |
True |
Ointment |
Inferred relationship |
Some |
|
Eye ointment |
Has basic dose form (attribute) |
True |
Ointment |
Inferred relationship |
Some |
|
Ear ointment |
Has basic dose form (attribute) |
True |
Ointment |
Inferred relationship |
Some |
|
Conventional release transdermal ointment (dose form) |
Has basic dose form (attribute) |
True |
Ointment |
Inferred relationship |
Some |
|
Gingival ointment |
Has basic dose form (attribute) |
True |
Ointment |
Inferred relationship |
Some |
|
Conventional release ear or eye ointment (dose form) |
Has basic dose form (attribute) |
True |
Ointment |
Inferred relationship |
Some |
|
Conventional release oral ointment (dose form) |
Has basic dose form (attribute) |
True |
Ointment |
Inferred relationship |
Some |
|
Conventional release vapor ointment for inhalation (dose form) |
Has basic dose form (attribute) |
True |
Ointment |
Inferred relationship |
Some |
|
Conventional release ear or eye or nose ointment (dose form) |
Has basic dose form (attribute) |
True |
Ointment |
Inferred relationship |
Some |
|